The effect of circulating adiponectin levels on incident gestational diabetes mellitus: systematic review and meta‑analysis

References

• Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS [Internet]. 10th edition. Brussels: International Diabetes Federation; 2021.
   Google Scholar
• Ye W, Luo C, Huang J, et al. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377:1. doi: 10.1136/bmj-2021-067946.
   Google Scholar
• Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62(6):905–915. doi: 10.1007/s00125-019-4840-2.
   PubMed Web of Science ®Google Scholar
• Vounzoulaki E, Khunti K, Abner SC, et al. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020;369:m1361. doi: 10.1136/bmj.m1361.
   PubMed Web of Science ®Google Scholar
• Chodick G, Tenne Y, Barer Y, et al. Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study. BMJ Open Diabetes Res Care. 2020;8(1):e000870. doi: 10.1136/bmjdrc-2019-000870.
   PubMed Web of Science ®Google Scholar
• Pathirana MM, Lassi ZS, Ali A, et al. Association between metabolic syndrome and gestational diabetes mellitus in women and their children: a systematic review and meta-analysis. Endocrine. 2021;71(2):310–320. doi: 10.1007/s12020-020-02492-1.
   PubMed Web of Science ®Google Scholar
• Lowe WLJr, Scholtens DM, Kuang A, et al. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care. 2019;42(3):372–380. doi: 10.2337/dc18-1646.
   PubMed Web of Science ®Google Scholar
• Rowland J, Wilson CA. The association between gestational diabetes and ASD and ADHD: a systematic review and meta-analysis. Sci Rep. 2021;11(1):5136. doi: 10.1038/s41598-021-84573-3.
   PubMed Web of Science ®Google Scholar
• Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115(3):485–491. doi: 10.1172/JCI24531.
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Blüher M, Stumvoll M. Adipokines in gestational diabetes. Lancet Diabetes Endocrinol. 2014;2(6):488–499. doi: 10.1016/S2213-8587(13)70176-1.
   PubMed Web of Science ®Google Scholar
• Zavalza-Gómez AB, Anaya-Prado R, Rincón-Sánchez AR, et al. Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract. 2008;80(1):8–15. doi: 10.1016/j.diabres.2007.12.012.
   PubMed Web of Science ®Google Scholar
• Li S, Shin HJ, Ding EL, et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302(2):179–188. doi: 10.1001/jama.2009.976.
   PubMed Web of Science ®Google Scholar
• Iliodromiti S, Sassarini J, Kelsey TW, et al. Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis. Diabetologia. 2016;59(4):692–699. doi: 10.1007/s00125-015-3855-6.
   PubMed Web of Science ®Google Scholar
• Schuitemaker JHN, Beernink RHJ, Franx A, et al. First trimester secreted Frizzled-related protein 4 and other adipokine serum concentrations in women developing gestational diabetes mellitus. PLOS One. 2020;15(11):e0242423. doi: 10.1371/journal.pone.0242423.
   PubMed Web of Science ®Google Scholar
• Ye Y, Wu P, Wang Y, et al. Adiponectin, leptin, and leptin/adiponectin ratio with risk of gestational diabetes mellitus: a prospective nested case-control study among Chinese women. Diabetes Res Clin Pract. 2022;191:110039. doi: 10.1016/j.diabres.2022.110039.
   PubMed Web of Science ®Google Scholar
• Florian AR, Cruciat G, Pop RM, et al. Predictive role of altered leptin, adiponectin and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid secretion in gestational diabetes mellitus. Exp Ther Med. 2021;21(5):520. doi: 10.3892/etm.2021.9951.
   PubMed Web of Science ®Google Scholar
• Al-Musharaf S, Sabico S, Hussain SD, et al. Inflammatory and adipokine status from early to midpregnancy in Arab women and its associations with gestational diabetes mellitus. Dis Markers. 2021;2021:8862494. doi: 10.1155/2021/8862494.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012. doi: 10.1001/jama.283.15.2008.
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B, O’connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 2022 Nov]. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm
   Google Scholar
• Roshanzamir F, Miraghajani M, Rouhani MH, et al. The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies. J Endocrinol Invest. 2018;41(1):33–47. doi: 10.1007/s40618-017-0697-8.
   PubMed Web of Science ®Google Scholar
• Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–1805. doi: 10.1177/0962280216669183.
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2.
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi: 10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Blettner M, Sauerbrei W, Schlehofer B, et al. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol. 1999;28(1):1–9. doi: 10.1093/ije/28.1.1.
   PubMed Web of Science ®Google Scholar
• Abell SK, Shorakae S, Boyle JA, et al. Role of serum biomarkers to optimise a validated clinical risk prediction tool for gestational diabetes. Aust N Z J Obstet Gynaecol. 2019;59(2):251–257. doi: 10.1111/ajo.12833.
   PubMed Web of Science ®Google Scholar
• Correa PJ, Venegas P, Palmeiro Y, et al. First trimester prediction of gestational diabetes mellitus using plasma biomarkers: a case-control study. J Perinat Med. 2019;47(2):161–168. doi: 10.1515/jpm-2018-0120.
   PubMed Web of Science ®Google Scholar
• Coussa A, Hasan HA, Barber TM. Early predictors of gestational diabetes mellitus in IVF-Conceived pregnancies. Endocr Pract. 2021;27(6):579–585. doi: 10.1016/j.eprac.2020.10.020.
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Echiburú B, Maliqueo MM, et al. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Hum Reprod. 2007;22(7):1830–1836. doi: 10.1093/humrep/dem090.
   PubMed Web of Science ®Google Scholar
• Xiao L, Zhao JP, Nuyt AM, et al. Female fetus is associated with greater maternal insulin resistance in pregnancy. Diabet Med. 2014;31(12):1696–1701. doi: 10.1111/dme.12562.
   PubMed Web of Science ®Google Scholar
• Yang X, Ye Y, Wang Y, et al. Association between early-pregnancy serum C-peptide and risk of gestational diabetes mellitus: a nested case-control study among Chinese women. Nutr Metab. 2022;19(1):56. doi: 10.1186/s12986-022-00691-3.
   Google Scholar
• Abell SK, Shorakae S, Harrison CL, et al. The association between dysregulated adipocytokines in early pregnancy and development of gestational diabetes. Diabetes Metab Res Rev. 2017;33(8). doi: 10.1002/dmrr.2926.
   PubMed Web of Science ®Google Scholar
• Corcoran SM, Achamallah N, Loughlin JO, et al. First trimester serum biomarkers to predict gestational diabetes in a high-risk cohort: striving for clinically useful thresholds. Eur J Obstet Gynecol Reprod Biol. 2018;222:7–12. doi: 10.1016/j.ejogrb.2017.12.051.
   PubMed Web of Science ®Google Scholar
• Ferreira AF, Rezende JC, Vaikousi E, et al. Maternal serum visfatin at 11–13 weeks of gestation in gestational diabetes mellitus. Clin Chem. 2011;57(4):609–613. doi: 10.1373/clinchem.2010.159806.
   PubMed Web of Science ®Google Scholar
• Francis EC, Li M, Hinkle SN, et al. Adipokines in early and mid-pregnancy and subsequent risk of gestational diabetes: a longitudinal study in a multiracial cohort. BMJ Open Diab Res Care. 2020;8(1):e001333. doi: 10.1136/bmjdrc-2020-001333.
   PubMed Web of Science ®Google Scholar
• Gao XL, Yang HX, Zhao Y. Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J (Engl). 2008;121(8):701–705.
   PubMed Web of Science ®Google Scholar
• Georgiou HM, Lappas M, Georgiou GM, et al. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol. 2008;45(3):157–165. doi: 10.1007/s00592-008-0037-8.
   PubMed Web of Science ®Google Scholar
• Ianniello F, Quagliozzi L, Caruso A, et al. Low adiponectin in overweight/obese women: association with diabetes during pregnancy. Eur Rev Med Pharmacol Sci. 2013;17(23):3197–3205.
   PubMed Web of Science ®Google Scholar
• Lacroix M, Battista MC, Doyon M, et al. Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care. 2013;36(6):1577–1583. doi: 10.2337/dc12-1731.
   PubMed Web of Science ®Google Scholar
• Lain KY, Daftary AR, Ness RB, et al. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf). 2008;69(3):407–411. doi: 10.1111/j.1365-2265.2008.03198.x.
   PubMed Web of Science ®Google Scholar
• Lee SM, Kwak SH, Koo JN, et al. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. Diabetologia. 2019;62(2):238–248. doi: 10.1007/s00125-018-4779-8.
   PubMed Web of Science ®Google Scholar
• Lomakova YD, Chen X, Stein TP, et al. Decreased adiponectin levels in early pregnancy are associated with high risk of prematurity for African American women. J Clin Med. 2022;11(11):3213. doi: 10.3390/jcm11113213.
   PubMed Web of Science ®Google Scholar
• Madhu SV, Bhardwaj S, Jhamb R, et al. Prediction of gestational diabetes from first trimester serum adiponectin levels in Indian women. Indian J Endocrinol Metab. 2019;23(5):536–539. doi: 10.4103/ijem.IJEM_319_19.
   PubMedGoogle Scholar
• Maitland RA, Seed PT, Briley AL, et al. Prediction of gestational diabetes in obese pregnant women from the UK pregnancies better eating and activity (UPBEAT) pilot trial. Diabet Med. 2014;31(8):963–970. doi: 10.1111/dme.12482.
   PubMed Web of Science ®Google Scholar
• Nanda S, Savvidou M, Syngelaki A, et al. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn. 2011;31(2):135–141. doi: 10.1002/pd.2636.
   PubMed Web of Science ®Google Scholar
• Paradisi G, Ianniello F, Tomei C, et al. Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes. Gynecol Endocrinol. 2010;26(7):539–545. doi: 10.3109/09513591003632084.
   PubMed Web of Science ®Google Scholar
• Ramachandrayya SA, D’Cunha P, Rebeiro C. Maternal circulating levels of adipocytokines and insulin resistance as predictors of gestational diabetes mellitus: preliminary findings of a longitudinal descriptive study. J Diabetes Metab Disord. 2020;19(2):1447–1452. doi: 10.1007/s40200-020-00672-4.
   PubMed Web of Science ®Google Scholar
• Ravnsborg T, Andersen LL, Trabjerg ND, et al. First-trimester multimarker prediction of gestational diabetes mellitus using targeted mass spectrometry. Diabetologia. 2016;59(5):970–979. doi: 10.1007/s00125-016-3869-8.
   PubMed Web of Science ®Google Scholar
• Savvidou M, Nelson SM, Makgoba M, et al. First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes. 2010;59(12):3017–3022. doi: 10.2337/db10-0688.
   PubMed Web of Science ®Google Scholar
• Sweeting AN, Wong J, Appelblom H, et al. A novel early pregnancy risk prediction model for gestational diabetes mellitus. Fetal Diagn Ther. 2019;45(2):76–84. doi: 10.1159/000486853.
   PubMed Web of Science ®Google Scholar
• Thagaard IN, Krebs L, Holm JC, et al. Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study. Clin Chem Lab Med. 2017;55(11):1805–1812. doi: 10.1515/cclm-2017-0427.
   PubMed Web of Science ®Google Scholar
• White SL, Lawlor DA, Briley AL, et al. Early antenatal prediction of gestational diabetes in obese women: development of prediction tools for targeted intervention. PLOS One. 2016;11(12):e0167846. doi: 10.1371/journal.pone.0167846.
   PubMed Web of Science ®Google Scholar
• Williams MA, Qiu C, Muy-Rivera M, et al. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab. 2004;89(5):2306–2311. doi: 10.1210/jc.2003-031201.
   PubMed Web of Science ®Google Scholar
• Yuan XS, Shi H, Wang HY, et al. Ficolin-3/adiponectin ratio for the prediction of gestational diabetes mellitus in pregnant women. J Diabetes Investig. 2018;9(2):403–410. doi: 10.1111/jdi.12688.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Hedderson MM, Quesenberry CP, et al. Central obesity increases the risk of gestational diabetes partially through increasing insulin resistance. Obesity. 2019;27(1):152–160. doi: 10.1002/oby.22339.
   PubMed Web of Science ®Google Scholar
• Bao W, Baecker A, Song Y, et al. Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: a systematic review. Metabolism. 2015;64(6):756–764. doi: 10.1016/j.metabol.2015.01.013.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhao YH, Chen YP, et al. Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. ScientificWorldJournal. 2014;2014:926932. doi: 10.1155/2014/926932.
   PubMed Web of Science ®Google Scholar
• Hedderson MM, Darbinian J, Havel PJ, et al. Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus. Diabetes Care. 2013;36(12):3930–3937. doi: 10.2337/dc13-0389.
   PubMed Web of Science ®Google Scholar
• Fuglsang J, Skjaerbaek C, Frystyk J, et al. A longitudinal study of serum adiponectin during normal pregnancy. BJOG. 2006;113(1):110–113. doi: 10.1111/j.1471-0528.2005.00792.x.
   PubMed Web of Science ®Google Scholar
• Retnakaran R, Qi Y, Connelly PW, et al. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia. 2010;53(2):268–276. doi: 10.1007/s00125-009-1600-8.
   PubMed Web of Science ®Google Scholar
• Thomann R, Rossinelli N, Keller U, et al. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome. Gynecol Endocrinol. 2008;24(4):199–206. doi: 10.1080/09513590801893398.
   PubMed Web of Science ®Google Scholar
• Sirico A, Rossi ED, Degennaro VA, et al. Placental diabesity: placental VEGF and CD31 expression according to pregestational BMI and gestational weight gain in women with gestational diabetes. Arch Gynecol Obstet. 2023;307(6):1823–1831. doi: 10.1007/s00404-022-06673-3.
   PubMed Web of Science ®Google Scholar
• Sirico A, Dell’Aquila M, Tartaglione L, et al. PTH-rP and PTH-R1 expression in placentas from pregnancies complicated by gestational diabetes: new insights into the pathophysiology of hyperglycemia in pregnancy. Diagnostics (Basel). 2021;11(8):1356. doi: 10.3390/diagnostics11081356.
   PubMedGoogle Scholar
• Mousa A, Abell SK, Shorakae S, et al. Relationship between vitamin D and gestational diabetes in overweight or obese pregnant women may be mediated by adiponectin.Mol Nutr Food Res. 2017;61(11). doi: 10.1002/mnfr.201700488.
   PubMed Web of Science ®Google Scholar
• Mir MM, Mir R, Alghamdi MAA, et al. Differential association of selected adipocytokines, adiponectin, leptin, resistin, visfatin and chemerin, with the pathogenesis and progression of type 2 diabetes mellitus (T2DM) in the Asir region of Saudi Arabia: a case control study. J Pers Med. 2022;12(5):735. doi: 10.3390/jpm12050735.
   PubMed Web of Science ®Google Scholar
• Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46(4):459–469. doi: 10.1007/s00125-003-1074-z.
   PubMed Web of Science ®Google Scholar
• Huang LT, Wu SL, Liao X, et al. Adiponectin gene polymorphisms and risk of gestational diabetes mellitus: a meta-analysis. World J Clin Cases. 2019;7(5):572–584. doi: 10.12998/wjcc.v7.i5.572.
   PubMed Web of Science ®Google Scholar
• Gong X, You L, Li F, et al. The association of adiponectin with risk of pre-diabetes and diabetes in different subgroups: cluster analysis of a general population in South China. Endocr Connect. 2021;10(11):1410–1419. doi: 10.1530/EC-21-0235.
   PubMed Web of Science ®Google Scholar
• Vecchiola A, García K, González-Gómez LM, et al. Plasminogen activator inhibitor-1 and adiponectin are associated with metabolic syndrome components. Am J Hypertens. 2022;35(4):311–318. doi: 10.1093/ajh/hpab138.
   PubMed Web of Science ®Google Scholar
• Orrù S, Nigro E, Mandola A, et al. A functional interplay between IGF-1 and adiponectin. Int J Mol Sci. 2017;18(10):2145. doi: 10.3390/ijms18102145.
   PubMed Web of Science ®Google Scholar
• Frankenberg ADV, Reis AF, Gerchman F. Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review. Arch Endocrinol Metab. 2017;61(6):614–622. doi: 10.1590/2359-3997000000316.
   PubMed Web of Science ®Google Scholar
• Xu A, Wang Y, Keshaw H, et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 2003;112(1):91–100. doi: 10.1172/JCI17797.
   PubMed Web of Science ®Google Scholar
• Wang Q, Du J, Liu F. Changes of serum adiponectin and glycated albumin levels in gestational diabetes mellitus patients and their relationship with insulin resistance. Iran J Public Health. 2020;49(7):1252–1261. doi: 10.18502/ijph.v49i7.3578.
   PubMed Web of Science ®Google Scholar
• Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol. 2002;13(1):51–59. doi: 10.1097/00041433-200202000-00008.
   PubMed Web of Science ®Google Scholar
• Mallardo M, Ferraro S, Daniele A, et al. GDM-complicated pregnancies: focus on adipokines. Mol Biol Rep. 2021;48(12):8171–8180. doi: 10.1007/s11033-021-06785-0.
   PubMed Web of Science ®Google Scholar